Literature DB >> 8436621

PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow.

R Uddman1, P J Goadsby, I Jansen, L Edvinsson.   

Abstract

Pituitary adenylate cyclase activating peptide (PACAP) is a vasoactive intestinal polypeptide (VIP)-like peptide recently isolated from ovine hypothalami. Nerve fibers containing PACAP immunoreactivity were present in the adventitia and the adventitia-media border of cat cerebral arteries. Double immunostaining revealed that PACAP-immunoreactive nerve fibers constituted a subpopulation of the VIP-containing fibers. PACAP effected a concentration-dependent relaxation of feline middle cerebral arteries that had been precontracted with prostaglandin F2 alpha. The maximum relaxation, 24 and 34% of precontraction, was achieved with PACAP-38 and PACAP-27, respectively, at a concentration of 10(-6) M. In cats anesthetized with alpha-chloralose, intracerebral microinjection of PACAP effected a moderate increase in cerebral blood flow. The maximal increase (18.6 +/- 6%) was observed following the injection of 5 micrograms PACAP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436621     DOI: 10.1038/jcbfm.1993.36

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  21 in total

Review 1.  The PACAP receptor: a novel target for migraine treatment.

Authors:  Henrik W Schytz; Jes Olesen; Messoud Ashina
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 2.  Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.

Authors:  Tahlia Sundrum; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

3.  Pituitary adenylate cyclase-activating peptide-immunoreactive nerve fibers in the cat eye.

Authors:  T Elsås; R Uddman; F Sundler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-09       Impact factor: 3.117

4.  Activation of PAC(1) and VPAC receptor subtypes elicits differential physiological responses from sympathetic preganglionic neurons in the anaesthetized rat.

Authors:  Melissa A Inglott; Ethan A Lerner; Paul M Pilowsky; Melissa M J Farnham
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 5.  Migraine is a neuronal disease.

Authors:  J Tajti; A Párdutz; E Vámos; B Tuka; A Kuris; Zs Bohár; A Fejes; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2010-12-15       Impact factor: 3.575

Review 6.  Neurogenic inflammation and its role in migraine.

Authors:  Roshni Ramachandran
Journal:  Semin Immunopathol       Date:  2018-03-22       Impact factor: 9.623

7.  The expression of VIP and SP in the cochlea of spontaneously hypertensive rats and its implication.

Authors:  Shusheng Gong; Juan Ding; Qing Chang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 8.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

9.  Pituitary adenylate cyclase activating polypeptide (PACAP) dilates cerebellar arteries through activation of large-conductance Ca(2+)-activated (BK) and ATP-sensitive (K ATP) K (+) channels.

Authors:  Masayo Koide; Arsalan U Syed; Karen M Braas; Victor May; George C Wellman
Journal:  J Mol Neurosci       Date:  2014-04-18       Impact factor: 3.444

10.  Pituitary adenylate cyclase-activating polypeptide does not colocalize with vasoactive intestinal polypeptide in the hypothalamic magnocellular nuclei and posterior pituitary of cats and rats.

Authors:  Viktoria Vereczki; Katalin Köves; Zsuzsanna E Tóth; Akemichi Baba; Hitoshi Hashimoto; Kristóf Fógel; Akira Arimura; Mária Kausz
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.